New 2017 FDA Approved Drugs
Cardiology/Vascular Diseases Bevyxxa (betrixaban); Portola Pharmaceuticals; For the the prophylaxis of venous thromboembolism, Approved June 2017
Read More »Cardiology/Vascular Diseases Bevyxxa (betrixaban); Portola Pharmaceuticals; For the the prophylaxis of venous thromboembolism, Approved June 2017
Read More »